Skip to content

HARMONY Study (Hypertension Analysis of Stress Reduction Using Mindfulness Meditation and Yoga)

HARMONY Study (Hypertension Analysis of Stress Reduction Using Mindfulness Meditation and Yoga)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00825526
Acronym
HARMONY
Enrollment
101
Registered
2009-01-21
Start date
2008-07-31
Completion date
Unknown
Last updated
2012-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Mindfulness Based Stress Reduction (MBSR), Stress Reduction, hypertension, high blood pressure, ambulatory blood pressure monitoring

Brief summary

The purpose of this study is to determine if Mindfulness Based Stress Reduction (MBSR) is an effective intervention for lowering blood pressure in early unmedicated hypertensives.

Interventions

BEHAVIORALMindfulness Based Stress Reduction (MBSR) Therapy

The objectives of MBSR therapy are to 1) understand their personal response to stress and 2) develop techniques to change the way these patients respond and cope with stress

Sponsors

University Health Network, Toronto
CollaboratorOTHER
Sunnybrook Health Sciences Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age 20 to 75 years 2. Hypertension by ABPM at baseline (daytime \> 135/85 mmHg or 24-hour ABPM \> 130/80 mmHg)

Exclusion criteria

1. Use of antihypertensive within 6 months of the screening ABPM. 2. Screening office BP \> 180/100 and ABPM \> 160/100 mmHg. 3. Diabetes 4. Secondary hypertension 5. Renal disease (GFR \< 60 ml/min or overt nephropathy) 6. History of heart attack 7. Stroke or TIA or 8. Re-vascularization procedure. 9. Active malignant disease (except non-melanoma skin cancer) 10. Epileptic seizure 6 months before the screening visit. 11. Congestive heart failure 12. Severe liver disease 13. Pregnancy or lactation period 14. Participation in a clinical trial or receipt of investigational compound or treatment in the 3 months prior to the initial screening visit. 15. Planned elective surgery during the study period except for cataract surgery

Design outcomes

Primary

MeasureTime frame
The primary outcome is the difference in 24-hour systolic and diastolic blood pressure between the treatment and wait-list group for the 12-week primary assessment period.12 weeks

Secondary

MeasureTime frame
Changes in 24 hour ambulatory systolic and diastolic blood pressure at the end of the treatment assessment period compared to the beginning.12 weeks
Between and within group comparisons of MBSR on blood pressure at different times of the day including daytime, night time and work time.24 weeks
The proportion of patients achieving blood pressure targets (24-hour ABPM<130/80 mmHg, daytime ABPM<135/85 mmHg) at the end of the Primary Outcome period24 weeks
The effect of MBSR on ambulatory blood pressure by gender24 weeks

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026